WOS: 000294384000008PubMed ID: 21756380Purpose: The PSA recurrence develops in 27 to 53% within ten years after radical prostatectomy (RP). We investigated the factors (disease grade and stage or the surgeon's expertise,) more likely to influence biochemical recurrence in men post-radical prostatectomy for organ-confined prostate cancer by different surgeons in the same institution. Materials and Methods: A total of 510 patients that underwent radical prostatectomy were investigated retrospectively. Biochemical recurrence was defined as detection of a PSA level of >= 0.20 ng/mL by two subsequent measurements. The causes, which are likely to influence the development of PSA recurrence, were separated into two groups as those related to the d...
The predictive factors for biochemical recurrence (BCR) were investigated in patients with positive ...
Prostate cancer is one of the most common urological malignancies managed by a practicing urologist....
The hypersensitive prostate specific antigen (PSA) test can measure in 0.01 ng/mL units, and its eff...
PubMed ID: 21756380Purpose: The PSA recurrence develops in 27 to 53% within ten years after radical ...
Objective: The main objective of this study was to evaluate the factors predicting recurrence in pat...
ABSTRACT Background Radical prostatectomy (RP) has been used as the main primary treatment for pros...
OBJECTIVE: The aim of this study was to determine factors associated with the development of biochem...
Radical prostatectomy (RP) represents the most frequently chosen therapeutic option for treating new...
Radical prostatectomy (RP) represents the most frequently chosen therapeutic option for treating new...
Objective: The aim of this study was to determine factors associated with the development of biochem...
Prostate cancer is one of the most common cancers in Western countries and is associated with a cons...
Purpose To analyze controversial clinicopathologic predictors of biochemical recurrence after surger...
<p><strong><em>Purpose. </em></strong><em>To reveal prognostic factors of PSA-failure following radi...
Objective: Although surveillance after radical prostatectomy routinely includes repeated prostate sp...
Objective: Although surveillance after radical prostatectomy routinely includes repeated prostate sp...
The predictive factors for biochemical recurrence (BCR) were investigated in patients with positive ...
Prostate cancer is one of the most common urological malignancies managed by a practicing urologist....
The hypersensitive prostate specific antigen (PSA) test can measure in 0.01 ng/mL units, and its eff...
PubMed ID: 21756380Purpose: The PSA recurrence develops in 27 to 53% within ten years after radical ...
Objective: The main objective of this study was to evaluate the factors predicting recurrence in pat...
ABSTRACT Background Radical prostatectomy (RP) has been used as the main primary treatment for pros...
OBJECTIVE: The aim of this study was to determine factors associated with the development of biochem...
Radical prostatectomy (RP) represents the most frequently chosen therapeutic option for treating new...
Radical prostatectomy (RP) represents the most frequently chosen therapeutic option for treating new...
Objective: The aim of this study was to determine factors associated with the development of biochem...
Prostate cancer is one of the most common cancers in Western countries and is associated with a cons...
Purpose To analyze controversial clinicopathologic predictors of biochemical recurrence after surger...
<p><strong><em>Purpose. </em></strong><em>To reveal prognostic factors of PSA-failure following radi...
Objective: Although surveillance after radical prostatectomy routinely includes repeated prostate sp...
Objective: Although surveillance after radical prostatectomy routinely includes repeated prostate sp...
The predictive factors for biochemical recurrence (BCR) were investigated in patients with positive ...
Prostate cancer is one of the most common urological malignancies managed by a practicing urologist....
The hypersensitive prostate specific antigen (PSA) test can measure in 0.01 ng/mL units, and its eff...